The complexity of liver surgery requires a comprehensive approach and deep experience

The experts at the Digestive Health Institute have been at the forefront in the adoption and application of robotic surgery for conditions of the digestive system. DHI offers the latest and most advanced options, including minimally invasive and robotic surgical techniques for those who require liver resection for survival. As the third busiest robotic liver program in the United States, our surgeons will perform more than 200 robotic liver operations this year.


Why Robotic

Robotic surgery is one of the most innovative advancements in medicine in recent decades. Our da Vinci Robotic Surgical System allows our expert physicians to remove liver tumors of all sizes, using small incisions, with extreme precision. Patients who undergo robotic surgery can expect significant benefits, such as:

Shorter hospital stays — most patients are discharged within 2-3 days following robotic liver resection surgery.

Reduced post-operative complications — cardiac and pulmonary complications following surgery are significantly lower than cases that involve large, open incision, and more invasive techniques. Risks for wound infections and the development of hernias are also greatly reduced.

Reduced blood loss — there is less blood loss during surgery and the need for blood transfusions before and following surgery is greatly minimized.

Less scaring and less pain — because the incisions are smaller and the surgical procedure is more targeted, most patients report minimal pain and / or donít require as much pain medication throughout their recovery period.

Expedited recovery — patients can return to work, family and social activities, and normal functionality, much quicker than would be the case if a traditional ìopenî surgery was performed.

Expedited care process — patients whose care plan involves chemotherapy or other post-surgical interventions can move into these phases of treatment sooner.

In addition, for patients with cancer, a robotic approach contributes to improved outcomes by allowing for the minimally invasive examination of the entire abdominal cavity for tumors and surface lesions (often not seen on CT scan), as well as direct liver ultrasonographic assessment which increases the detection of lesions by ten percent (as compared to CT scan and MRI).


Surgery v. Ablation

While ablation is often promoted as a solution for liver lesions, multi-institutional studies indicate the rate of recurrence is far greater with ablation than with surgical resection, especially for lesions >3 cm. Therefore in most cases, surgery is the preferred and most effective approach. In the rarer case that ablation would be deemed appropriate for a patient after a thorough preoperative evaluation, we are able to offer it less invasively and more accurately with a laparoscopic, single-incision or robotic procedure.

Alexander Rosemurgy, MD, FACS

With more than three decades of experience, Dr. Rosemurgy serves as the Medical Director for the Digestive Health Institute at Florida Hospital Tampa. He is an advanced GI surgeon, specializing in minimally invasive and robotic surgery for disorders of the esophagus, stomach, small bowel, pancreas and liver.


Iswanto Sucandy, MD

Dr. Sucandy is a highly-experienced, board-certified surgeon with fellowship training in hepatobilliary and pancreatic surgery, as well as advanced gastointestinal minimally invasive surgery for disorders of the liver.

 

The Digestive Health Institute provides priority access for your oncology patients.
To refer a patient, please call (813) 615-7491.